Cells,
Год журнала:
2023,
Номер
12(14), С. 1872 - 1872
Опубликована: Июль 17, 2023
The
CNS
is
very
susceptible
to
oxidative
stress;
the
gut
microbiota
plays
an
important
role
as
a
trigger
of
damage
that
promotes
mitochondrial
dysfunction,
neuroinflammation,
and
neurodegeneration.
In
current
review,
we
discuss
recent
findings
on
oxidative-stress-related
inflammation
mediated
by
gut–brain
axis
in
multiple
sclerosis
(MS).
Growing
evidence
suggests
targeting
can
be
promising
strategy
for
MS
management.
Intricate
interaction
between
factors
leads
increased
intra-
inter-individual
heterogeneity,
frequently
painting
different
picture
vivo
from
obtained
under
controlled
conditions.
Following
evidence-based
approach,
all
proposed
interventions
should
validated
clinical
trials
with
cohorts
large
enough
reach
significance.
Our
review
summarizes
existing
focused
identifying
suitable
interventions,
combinations,
appropriate
timings
target
microbiota-related
stress.
Most
studies
assessed
relapsing–remitting
(RRMS);
only
few
limited
were
carried
out
other
stages
(e.g.,
secondary
progressive
MS–SPMS).
Future
must
consider
extended
time
frame,
perhaps
starting
perinatal
period
lasting
until
young
adult
period,
aiming
capture
many
complex
intersystem
interactions
possible.
Current Issues in Molecular Biology,
Год журнала:
2024,
Номер
46(8), С. 8852 - 8873
Опубликована: Авг. 14, 2024
Reactive
oxygen
species
(ROS)
are
widely
regarded
as
signaling
molecules
and
play
essential
roles
in
various
cellular
processes,
but
when
present
excess,
they
can
lead
to
oxidative
stress
(OS).
Growing
evidence
suggests
that
the
OS
plays
a
critical
role
pathogenesis
of
HIV
infection
is
associated
with
several
comorbidities
HIV-infected
individuals.
ROS,
generated
both
naturally
during
mitochondrial
metabolism
response
trigger
host
antiviral
responses
also
promote
viral
replication.
While
multifaceted
ROS
pathophysiology
clearly
need
more
investigation,
this
review
paper
unravels
mechanisms
generation
context
infections,
offering
insights
into
protein-mediated
antiretroviral
therapy-generated
OS.
Though
protein
Tat
significantly
attributed
endogenous
increase
post
infection,
sums
up
contribution
other
proteins
HIV-mediated
elicitation
ROS.
Given
investigations
recognizing
significant
onset
progression
diverse
pathologies,
explores
function
mediation
an
array
pathologies
retroviral
therapy.
patients
observed
disruption
antioxidant
defense
system,
therapy
gaining
focus
potential
therapeutic
intervention
well
discussed.
scenario,
further
exploratory
studies
imperative
identifying
alternative
strategies
could
mitigate
toxicities
ART-induced
Neurochemistry International,
Год журнала:
2023,
Номер
172, С. 105655 - 105655
Опубликована: Дек. 9, 2023
The
majority
of
traumatic
brain
injuries
(TBIs),
approximately
90%,
are
classified
as
mild
(mTBIs).
Globally,
an
estimated
4
million
occur
each
year
from
concussions
or
mTBIs,
highlighting
their
significance
a
public
health
crisis.
TBIs
can
lead
to
substantial
long-term
consequences,
including
increased
risk
developing
Alzheimer's
Disease,
Parkinson's
Disease
(PD),
chronic
encephalopathy
(CTE),
and
nearly
doubling
one's
suicide.
However,
the
current
management
mTBIs
in
clinical
practice
available
treatment
options
limited.
There
exists
unmet
need
for
effective
therapy.
This
review
addresses
various
aspects
based
on
most
up-to-date
literature
review,
with
goal
stimulating
translational
research
identify
new
therapeutic
targets
improve
our
understanding
pathogenic
mechanisms.
First,
we
provide
summary
mTBI
symptomatology
diagnostic
parameters
such
Glasgow
Coma
Scale
(GCS)
classifying
concussions,
well
utility
alternative
parameters,
imaging
techniques
like
MRI
diffusion
tensor
(DTI)
serum
biomarkers
S100B,
NSE,
GFAP,
UCH-L1,
NFL,
t-tau.
Our
highlights
several
pre-clinical
concussion
models
employed
study
underlying
cellular
mechanisms
involved
mTBI-related
pathogenesis,
axonal
damage,
demyelination,
inflammation,
oxidative
stress.
Finally,
examine
selection
currently
under
investigation
models.
These
may
hold
promise
translation
address
pressing
more
treatments
mTBIs.
Antioxidants,
Год журнала:
2024,
Номер
13(2), С. 220 - 220
Опубликована: Фев. 8, 2024
Phospholipases
(PL)
A2
catalyzes
the
hydrolysis
of
membrane
phospholipids
and
mostly
generates
arachidonic
acid
(AA).
The
enzyme
5-lipoxygenase
(5-LOX)
can
metabolize
AA
to
obtain
inflammatory
leukotrienes,
whose
biosynthesis
highly
depends
on
cPLA2
5-LOX
activities.
Formyl
Peptide
Receptor
2
(FPR2)
belongs
a
subfamily
class
A
GPCRs
is
considered
most
versatile
FPRs
isoform.
Signaling
triggered
by
FPR2
includes
activation
several
downstream
kinases
NADPH
oxidase
(NOX)-dependent
ROS
generation.
In
metabolomic
analysis
we
observed
significant
increase
in
concentration
FPR2-stimulated
lung
cancer
cell
line
CaLu-6.
We
analyzed
phosphorylation
time-dependent
Ser505
cells,
which
was
prevented
MEK
inhibitor
(PD098059)
p38MAPK
(SB203580)
blocking
NOX
function.
Similarly,
demonstrated
that
at
Ser271
Ser663
residues
requires
FPR2-dependent
ERKs
activation.
Moreover,
showed
functional
expression.
Our
overall
data
demonstrate
for
first
time
FPR2-induced
ERK-
p38MAPK-dependent
phosphorylation/activation
oxidase.
These
findings
represent
an
important
step
towards
future
novel
therapeutic
possibilities
aimed
resolving
processes
underlying
many
human
diseases.
Cells,
Год журнала:
2023,
Номер
12(14), С. 1872 - 1872
Опубликована: Июль 17, 2023
The
CNS
is
very
susceptible
to
oxidative
stress;
the
gut
microbiota
plays
an
important
role
as
a
trigger
of
damage
that
promotes
mitochondrial
dysfunction,
neuroinflammation,
and
neurodegeneration.
In
current
review,
we
discuss
recent
findings
on
oxidative-stress-related
inflammation
mediated
by
gut–brain
axis
in
multiple
sclerosis
(MS).
Growing
evidence
suggests
targeting
can
be
promising
strategy
for
MS
management.
Intricate
interaction
between
factors
leads
increased
intra-
inter-individual
heterogeneity,
frequently
painting
different
picture
vivo
from
obtained
under
controlled
conditions.
Following
evidence-based
approach,
all
proposed
interventions
should
validated
clinical
trials
with
cohorts
large
enough
reach
significance.
Our
review
summarizes
existing
focused
identifying
suitable
interventions,
combinations,
appropriate
timings
target
microbiota-related
stress.
Most
studies
assessed
relapsing–remitting
(RRMS);
only
few
limited
were
carried
out
other
stages
(e.g.,
secondary
progressive
MS–SPMS).
Future
must
consider
extended
time
frame,
perhaps
starting
perinatal
period
lasting
until
young
adult
period,
aiming
capture
many
complex
intersystem
interactions
possible.